On World Kidney Day: from early detection to access to kidney disease treatment
| datacite.rights | http://purl.org/coar/access_right/c_abf2 | |
| dc.contributor.author | Sánchez-Polo, Vicente | |
| dc.contributor.author | daza arnedo, rodrigo andres | |
| dc.contributor.author | Villavicencio Ceron, Vanessa | |
| dc.contributor.author | Álvarez-Estévez, Guillermo | |
| dc.contributor.author | Rico-Fontalvo, Jorge | |
| dc.date.accessioned | 2025-03-27T16:36:37Z | |
| dc.date.available | 2025-03-27T16:36:37Z | |
| dc.date.issued | 2025 | |
| dc.description.abstract | As every year, World Kidney Day will be celebrated on March 13th, prompting educational campaigns worldwide aimed at raising awareness among the general population about kidney care. Given that chronic kidney disease (CKD) has a significant impact on quality of life, morbidity, and mortality, it is crucial to use this opportunity to raise its visibility among the public. It is estimated that approximately 10% of the global population suffers from some form of CKD, with 78% residing in low- or middle-income countries. These regions also face challenges such as malnutrition, infection risks, low birth weight, environmental factors, and limited access to healthcare services | eng |
| dc.format.mimetype | ||
| dc.identifier.doi | 10.24875/NEFRO.M25000063 | |
| dc.identifier.issn | 24449032 (Electrónico) | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12442/16403 | |
| dc.identifier.url | https://www.nefrologialatinoamericana.com/frame_eng.php?id=167 | |
| dc.language.iso | eng | |
| dc.publisher | Sociedad Latinoamericana de Nefrología e Hipertensión | spa |
| dc.rights | Attribution-NonCommercial-NoDerivs 3.0 United States | eng |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess | |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/us/ | |
| dc.source | Nefrología Latinoamericana | spa |
| dc.source | Nefro Latinoam. | eng |
| dc.source | Vol. 22 No. 1 Año 2025 | spa |
| dc.title | On World Kidney Day: from early detection to access to kidney disease treatment | eng |
| dc.title.translated | A propósito del Día Mundial del Riñón: de la detección temprana al acceso al tratamiento de la enfermedad renal | spa |
| dc.type.driver | info:eu-repo/semantics/article | |
| dc.type.spa | Artículo científico | |
| dcterms.references | Correa-Rotter R, Méndez Durán A, Vallejos A, Rico-Fontalvo J, Cusumano AM, Rosa-Diez GJ, et al. Unmet needs of CKD in Latin America:a review from expert virtual working group. Kidney Int Rep. 2023;8:954-67. | eng |
| dcterms.references | Calice-Silva V, Neyra JA, Ferreiro Fuentes A, Massai KK, Arruebo S, Bello AK, et al. Capacity for the management of kidney failure in the International society of nephrology Latin America region:report from the 2023 ISN global kidney health Atlas (ISN-GKHA). Kidney Int Suppl (2011). 2024;13:43-56. | eng |
| dcterms.references | Arici M, Assaad-Khalil SH, Bertoluci MC, Choo J, Lee YJ, Madero M, et al. Results from a cross-specialty consensus on optimal management of patients with chronic kidney disease (CKD):from screening to complications. BMJ Open. 2024;14:e080891. | eng |
| dcterms.references | Rico Fontalvo J, Elbert A, Lorca E, Daza-Arnedo R, Castellaro C, Villavicencio V, et al. Situación de la enfermedad renal en América Latina, con énfasis en la enfermedad renal diabética:dificultades y desafíos. Nefro Latinoam. 2024:1-11. | spa |
| dcterms.references | Sánchez-Polo V, Garcia-Trabanino R, Rodriguez GV, Madero M. Mesoamerican nephropathy (MeN):what we know so far. Int J Nephrol Renovasc Dis. 2020;13:261-72. | eng |
| dcterms.references | Bravo-Zúñiga JI, Carlino-Bauza MC, Ríos-Sarro PG, Zúñiga-San Martín CA, Cueto-Manzano AM, Zúñiga-Saravia EA, et al. Aportes para la creación de programas de salud renal en Latinoamérica, comitéde salud renal de la SLANH. Nefro Latinoam. 2024;21:40-52. | spa |
| dcterms.references | Obrador GT, Álvarez-Estévez G, Bellorín E, Bonanno-Hidalgo C, Clavero R, Correa-Rotter R, et al. Documento de consenso sobre nuevas terapias para retrasar la progresión de la enfermedad renal crónica con énfasis en los iSGLT-2:implicaciones para Latinoamérica. Nefro Latinoam. 2024;21:1-18. | spa |
| dcterms.references | Zannad F, McGuire DK, Ortiz A. Treatment strategies to reduce cardiovascular risk in persons with chronic kidney disease and type 2 diabetes. J Intern Med. 2024. | eng |
| dcterms.references | Rico Fontalvo J, Álvarez Estévez G, Sánchez Polo V, Dina Batlle E, Lorca Herrera E, Mascheroni C, et al. Consenso de la sociedad Latinoamericana de nefrología e hipertensión en relación con el papel de los antagonistas del receptor mineralocorticoide en enfermedad renal crónica. Nefrol Latinoam. 2022;19:116-28. | spa |
| oaire.version | info:eu-repo/semantics/publishedVersion |